Amgen CEO Robert Bradway met with President Donald Trump on Jan. 31 and vowed to add 1,600 jobs, Bloomberg News reported.

Trump told biotech leaders at a White House meeting that drug prices needed to come down and he would find a way to streamline the regulatory process.

He has discussed having the government negotiate directly with the health care industry on behalf of Medicare and Medicaid in order to curb prices.

In July 2014, Thousand Oaks-based Amgen announced it would run as a leaner company by cutting between 2,400 and 2,900 jobs worldwide — up to 15 percent of its 20,000 total workforce — and shutter facilities in Colorado and Washington.

Amgen shares increased close to 1.5 percent to $156.68 on Jan. 31.

• Contact Alex Kacik at akacik@pacbiztimes.com.